Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.
Ans:- When its a Polarean RNS !! ... some cruel joke.. and someone has it in for POLX or as previously mentioned forced sellers due to fund redemptions .. this should have finished in the blue today...
These are the Next Gen MRI machines being showcased at the International Society for Magnetic Resonance in Medicine Annual Meeting & Exhibition (ISMRM 2023, June 3-8, 2023, Toronto, Canada) - this is ground breaking - well done ...
https://www.philips.com/a-w/about/news/archive/standard/news/articles/2023/20230602-philips-break-through-mr-7700-system-adds-xenon-capabilities-to-enhance-ventilation-imaging-at-ismrm-2023.html
What no red this morning - do my eyes deceive me... I hope they've gone now ... but just went you think its safe to go back in the water! Roll on Monday - I've submitted about 8 questions... I think they will be inundated from us alone..
In my opinion nothing in the RNS was a surprise. I'm just personally frustrated at at how level-headed and unexcitable RH comes across and also that I haven't any spare cash to hoover up some stock at this price. There's been a complete over-reaction of the share price fueled by our regular big hitting sellers who've gone into overdrive this morning. Maybe I'm too invested but I don't see anything in this RNS to make me want to sell. They've mentioned a potential strategic tie up.. and still we have no board of directors buying shares .. why .. is it because they can't, because they are inside to knowledge of a strategic tie up? If I were a betting man then I'd put monry on this finishing the day above 40p by the end of the day and 45p by the end of the week.
So old 50 Cent aka "50k block trader" returned today ... wondered if they would.. boy they hate a price rise.. mixed it up with a couple of 40k sales too... I think this is driving me mad - so very irrational to think its the same person! I have 2 questions... Why oh why would you sell now.. and where are you RH!! (fingers crossed he's putting together a huge deal - RNS coming soon perhaps .. Friday would be a good day to relaease an RNS!!)
Seller seems to have reduced his/her trades from 20k to 10 & 5k lots ... but nearly always add up to an aggregate of £100k each time .. maybe a fixed reoccurring order instruction to their broker? ... This is defo (IMO) the same seller as they come in waves ... either 1) forced seller - maybe there is a fund liquidating or private investor in financial trouble or 2) someone trying to manipulate the share price down for their own gain - seems like their MO is to hit the share early doors and try and set the tone for the day? .... Anyway good to see some blue trades coming through.. what a bargain you are getting ...if I had spare cash I would join you all and top up ..
I am usually fairly measured and I am also a long term holder of POLX .. I hate any ramping/de-ramping but anyone else just p!ssed off with the seller/s.... Fantastic news out this afternoon went to 47/48 then bam ... they hit this with their constant 20/50/100k sales and I'm sure its the same seller each time (no evidence!)... Why would you sell now?... my mind plays tricks in that I wonder if they know something.. (doubt it) ..do they gain from a low share price somehow (force investors to be ever grateful for an eventual low ball offer?) .. are they short sellers banking on polx running out of cash (possibly)? Without he/she/them selling this would have roofed recently.. anyway I know its a free market with buyers/sellers and I should be patient ... but please let us enjoy a decent rally for once and stop hitting the damn sell button!
SP makes no sense .. getting back to levels near to when had no approval.. approval was apparently a binary outcome! They got approval .. so now massive potential … sales likely from those waiting for the approval will come through with new year budgets now unlocked…. hopefully the directors dip their toes in a bit more and purchase more shares to show confidence.. think in time we will all look back and wonder how on earth the stock came back to these levels post approval..
I'm a LTH (2yrs!) or LTL (Long time loser)! Everyday recently I've checked out the trades and they're always red - I know this site can print sell when its a buy but the prices struck suggest its been sell sell sell ... Today I just looked and I have to pick myself up as there is a 150,000 blue buy - please let this be real.. not moved yet but maybe this could give it a boost .. however small .. It would set me up for the weekend..
Agrred all a bit of a shambles really and you have to wonder why these queries haven't already been addressed.. However I was wondering this week if the share price action was indicative of ("a leak" ) the technology was going to be outright rejected... obviously some people did get wind of this news!!. After the initial shock of seeing the share price down and subsequently reading the RNS and also having access to the Stifel note I am starting to feel more positive than I did earlier this week. Yes bad news re the delays but positives outweigh this..my two takeaways are that the FDA are now fully engaged with Polarean / Linde rather than issuing another CRL next week, with all previous issues with the polarizer device having been resolved (positive news) and the FDA has no further issues here. So its now up to this leading German chemical company to meet regularly and sort this out in the next 90 days which they state they will.. I feel relatively confident that this will end well...
re: Linde & Nukem (this is in their June 2018 results... · identifying, evaluating and selecting a candidate, Linde who are one of the largest global industrial gas suppliers, and entering into agreements to package and distribute our proprietary 129Xe drug, in preparation for the Phase III clinical trials. We are fortunate to have Nukem Isotopes GmbH as a strategic investor and supplier of our enriched 129Xe raw material and we thank them for their support.
Last week I saw that the Amati AIM Vct fund had a final dividend payout on July 22nd - I did wonder if the sales were related in that the fund maybe needed to raise capital to fund this or needed to re-fill the cash bucket but then I dismissed that as I thought large share holders had to declare sales / purchases to the market - perhaps someone can clarify this .. as I'm not sure of the disclosure rules? Are they different for AIM?
You did well there ... I was trying to sell some stuff to buy more at these levels but HL couldn't fill me on an illiquid stock so think I missed my chance to buy at 41. Started the morning frantically searching the newsflow .. but nothing ... so unless someones in the know (doubtful) then this was likely a forced seller / possibly a fund needed to program trade all holdings to cover a redemption .... but with no news this was surely one of the last times to be able to buy at discounted levels while we run up to decision time!
Noticed a couple of 'larger then usual' purchases for this very sleepy stock.. I was prepared to throw the towel in yesterday but talked myself out of it as noticed they report on the 4th July and always enjoy the buzz of results day! Here's hoping they release market pleasing results along with some decent newsflow.
ReNeuron is a pureplay exosome developer, offering an elegant solution to issues facing the delivery of novel therapeutics. Demand for drug delivery technologies is high, and ReNeuron offers tissue-targeting, unique platform flexibility and the ability to target difficult-to-treat diseases. The success of others sets a clear path for appreciation, and we believe ReNeuron is the best way to play the exosome theme and the evolution of drug delivery technologies in the UK. It has pipeline of 7 partnered exosome programmes, securing a single licensing deal could underwrite the modest market cap. and unlock significant upside. Initiate on BUY with a TP of 80p.
Another great news release taken with as much excitement as watching grass grow... This is exactly what is needed .. the brains of the pulmonary world learning how to use the equipment so they can spread the word and highlight the advantages / usages of the tech and how to interpret the outputs. What makes someone read this RNS and then go and sell 20,000 shares?? So maybe there are forced sellers following market sell offs .. perhaps we have a few burnt crypto investors on the books and to be fair this stock has held up during the recent rout...and on a 2yr basis there are profits to be taken. The other possibility is there could be some selling before the results are released, which we all know numerically are not going to paint a pretty picture but for anyone who is close to this company will understand it is very much a jam tomorrow story... Maybe cash burn could be an issue but we have been assured numerous times enough cash was raised to get us though approval and more..
Makes no sense. I guess a lot of fingers were burnt previously and some have factored in there is a long wait - we're told 6 months and maybe they are choosing to de-risk / use funds elsewhere in the meantime. I thought about it but came to the conclusion there is more of a risk it could be approved way before 6 months. Don't think Vadim Alexandre / Justin Waite helped as they outlined the potential hurdles and not trusting the FDA etc.. I take comfort in that this is a completely un-ramped stock by management, well funded and in my opinion is more likely now than before to get approval, then very likely to be snapped up by Bracco. Patience will be rewarded I'm sure.
Shore Capital Stockbrokers
XP FACTORY+ (XPF, House Stock at 28p) –Positive FY21F trading update
We are most encouraged by XP Factory’s (XPF) trading update for H2 FY21F, which states that it expects to deliver a positive Group EBITDA (excluding R&D credits) in H2, ahead of City expectations. Following the completion on 23 November 2021 of the acquisition of the strategically-important Boom Battle Bar, owner-operated and franchised new sites have opened and are continuing to open, in line with expectations across both formats. We also note the £1.5m R&D grant XPF received in January 2022, which has bolstered the cash position. Ahead of the final results, we maintain our forecasts and reiterate our view that the site rollout being pursued will deliver a highly profitable and cash-generative experiential leisure group in due course. House stock.
Strong trading in H2 FY21F for Escape Hunt –Trading within the Escape Hunt network bounced back strongly after H1 21 and significantly exceeded the Board’s original expectations. In H2 21F, XPF expects £5.1m revenue from its owner-operated sites (133% up on the pre-pandemic H2 19 and site level EBITDA to exceed £2m in H2 (340% ahead of H2 19). This was driven by the enlarged estate, underlying like-for-like growth and improved margins.
Boom Battle Bar proceeding in line with plans-Since the acquisition, significant progress has been made in the development of the network with The O2 opening as an owner-operated site in December, and Wandsworth and Coventry opening as franchises. Eight additional sites (including two owner- operated) currently have building underway.
Investment case is intact–With the Group expected to show a positive adjusted EBITDA for H2 21, we believe that management’s strategy to build an experiential leisure group is being vindicated. Assuming sites continue to open in line with expectations we expect further strong pre-IFRS 16 EBITDA progress in FY22F, as detailed in our forecasts below. House stock.
Agree when I read through the rns I was pleasantly pleased and looking forward to some positive price action! topped up Monday so kicking myself I didn't wait until today... maybe there was an expectation of more clear indication towards the lloyds contract being solidified.. oh well seems like this is one to forget about for a while and look forward to the jam tomorrow.. still can't believe some bought under 60p ..lucky lucky them!!